Cardlytics Continues Income Contraction Surrounded By Deterioration Business Economics (NASDAQ: CDLX)

.Financial author highly recommends selling Cardlytics, Inc. due to decreasing device business economics, earnings problems, and also adverse monetary fads. Click for this CDLX upgrade.